References
- Mastropietro DJ, Omidian H. Abuse-deterrent formulations: part 1 - development of a formulation-based classification system. Expert Opin Drug Metab Toxicol. 2015;11(2):193–204.
- Henningfield JBAR. The new science of abuse-deterrence assessment of pharmaceutical products; FDA proposed guidance and category 1 laboratory studies. Pharmaceutica Analytica Acta. 2014;5(9).
- US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research [Internet]. Guidance for industry, abuse-deterrent opioids-evaluation and labeling; [cited 2015 Aug 21]. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM334743.pdf.
- Mastropietro DJ, Omidian H. Drug tampering and abuse deterrence. Journal of Developing Drugs. 2014;3(1).
- Raffa RB, Pergolizzi JV Jr. Opioid formulations designed to resist/deter abuse. Drugs. 2010 Sep;10(70):1657–1675.
- Van Hout MC. Kitchen chemistry: a scoping review of the diversionary use of pharmaceuticals for non-medicinal use and home production of drug solutions. Drug Test Anal. 2014 Jul–Aug;6:778–787.
- Mannion RO, O’donnell EP, Mckenna WH, et al. Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic. U.S. Pat. No. 8808741. 2008.
- Jain SK, Kadam VJ, Hirlekar RS. Study of effects of post-compressioon curing on Kollidon SR based floating tablets. Int J Pharm Pharm Sci. 2011;3:90.
- Back DM, Schmitt RL. Ethylene oxide polymers. In: Kirk-othmer, Editor. encyclopedia of chemical technology. 5th ed. John Wiley & Sons, Inc; 2004. Available from: http://onlinelibrary.wiley.com/doi/10.1002/0471238961.0520082502010311.a01.pub2/full
- McKenna WH, Mannion RO, O’Donnell EP, et al. Tamper resistant dosage forms. U.S. Pat. No. 8821929. 2014.
- Crowley MM, Zhang F, Koleng JJ, et al. Stability of polyethylene oxide in matrix tablets prepared by hot-melt extrusion. Biomaterials. 2002;23:4241–4248.
- Eisenhauer TD, Matchett M, Heasley R, et al. Evaluation of the tamper-resistant properties of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets. Drug Dev Ind Pharm. 2016;42(1):157–165.
- Vosburg SK, Jones JD, Manubay JM, et al. Assessment of a formulation designed to be crush-resistant in prescription opioid abusers. Drug Alcohol Depend. 2012 Nov 1126:206–215.
- Bartholomaeus JH, Arkenau-Maric E, Galia E. Opioid extended-release tablets with improved tamper-resistant properties. Expert Opin Drug Deliv. 2012 Aug;9:879–891.